Triple-Negative Breast Cancers: Unique Clinical Presentations and Outcomes

Author： Billar Julie Dueck Amylou Stucky Chee-Chee Gray Richard Wasif Nabil Northfelt Donald McCullough Ann Pockaj Barbara

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.17, Iss.3, 2010-10, pp. : 384-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Triple-Negative Breast Cancer: Unique Biology and Its Management

By Maegawa Rodrigo O. B. Tang Shou-Ching

Cancer Investigation, Vol. 28, Iss. 8, 2010-09 ,pp. : 878-883

Informa Healthcare

Access to resources Recommend Favorite

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer

By Asano Yuka Kashiwagi Shinichiro Goto Wataru Tanaka Sayaka Morisaki Tamami Takashima Tsutomu Noda Satoru Onoda Naoyoshi Ohsawa Masahiko Hirakawa Kosei Ohira Masaichi

Cancers, Vol. 9, Iss. 1, 2017-01 ,pp. : 4-4

MDPI

Access to resources Recommend Favorite

PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers

By Stebbing Justin Ellis Paul Tutt Andrew

Future Oncology, Vol. 6, Iss. 4, 2010-04 ,pp. : 485-486

Future Medicine

Access to resources Recommend Favorite

The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis

By Petrelli Fausto Coinu Andrea Borgonovo Karen Cabiddu Mary Ghilardi Mara Lonati Veronica Barni Sandro

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 223-232

Springer Publishing Company

Access to resources Recommend Favorite

Development of targeted therapies for triple-negative breast cancer: can we harness tumor heterogeneity to improve patient outcomes?

By Diamond Jennifer R Elias Anthony D

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 175-178

Future Medicine

Access to resources Recommend Favorite